Abstract ObjectiveThis study aimed to investigate the importance of cytochrome P 450 enzymes for the reported interaction between tramadol and warfarin. Materials and methodsCases of suspected interaction between tramadol and warfarin resulting in International Normalised Ratios increases that were reported to the Swedish Adverse Drug Reactions Advisory Committee until March 2003 were included. Ten cases had been genotyped for known polymorphisms of CYP2D6, CYP2C9 and CYP2C19. ResultsSeven of ten patients carried defective CYP2D6 alleles (population prevalence 42.2%) (one-sided binomial test, P=0.07). A further patient received concomitant drug treatments that may have resulted in CYP2D6 enzyme inhibition. ConclusionThe liability to an interaction between tramadol and warfarin may be related to the CYP2D6 activity.
enzymes             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme                

tramadol                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Tramadol              

cytochrome                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cytochrome            

CYP2D6                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CYP2D6                

polymorphisms                 0.9998006211798165^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Polymorphism_(biology)

CYP2D6                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CYP2D6                

warfarin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Warfarin              

Swedish                       0.9645788484619954^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Sweden                

CYP2D6                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CYP2D6                

warfarin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Warfarin              

binomial test                 0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Binomial_test         

tramadol                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Tramadol              

CYP2C19                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CYP2C19               

warfarin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Warfarin              

Adverse Drug Reactions Advisory Committee1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Adverse_Drug_Reactions_Advisory_Committee

alleles                       0.9999999999167812^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Allele                

CYP2C9                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CYP2C9                

tramadol                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Tramadol              

CYP2D6                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CYP2D6                

enzyme inhibition             0.9999548451415554^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

